Abstract
The article aims to examine technological, organizational and regulatory aspects of drug quality and safety assurance system, as well as peculiarities in civil circulation of extemporaneous drugs in Latvian pharmaceutical market to improve approaches for statutory regulation of this special and socially significant type of activity of pharmaceutical organizations. This work continues a series of articles about compounding pharmacy practice in different world healthcare systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have